Sign up to be notified
Want to stay updated on the work CABHI is doing with its partners to advance the aging and brain health innovation ecosystem?
< Back to all News
CABHI + OBIO work together to open doors for Ontario innovators
From February 3 to 5, 2026, CABHI sponsored and attended the OBIO Investment Summit—Canada’s premier health science investment event—bringing together innovators, investors, and ecosystem leaders shaping the future of health technology in Canada. CABHI and OBIO used the occasion to formally announce the next phase of their longstanding collaboration under a new MOU, solidifying a long and fruitful partnership that has grown and launched countless agetech innovations since 2020.
“CABHI and OBIO are each committed to accelerating homegrown health tech and agetech solutions while fueling Canada's economy,” said James Mayer, COO of CABHI. “With 20 companies already co-funded, solidifying this partnership allows us to pool resources, expand support, and ensure innovators have greater access to the opportunities they need to succeed.”
To date, 20 Ontario companies have been jointly funded by CABHI and OBIO. Under this newly formalized partnership, companies developing innovative solutions to challenges affecting older persons and caregivers will benefit from expanded access to coordinated programming, capital, and expertise, helping fast-track growth and commercialization.
Formalizing CABHI and OBIO’s partnership is a natural next step; one which Maura Campbell, President & CEO of OBIO, noted “injects fresh momentum into a rapidly growing sector”, opening doors to new opportunities for Canadian innovators.
Several CABHI team members were actively engaged throughout the multi-day summit. Mel Barsky, Director of Business Development, presented at the Early Technology Showcase, while Jesse Mastrangelo, Senior Program Manager, moderated a commercial sales panel featuring leaders from across the sector, sharing real-world insights on navigating adoption and scaling. The event also featured a vibrant CABHI-sponsored networking reception, kicked off by Jon Suckling, Director of Programs & Strategy, bringing together voices from across the ecosystem.
Also in attendance at the summit were several companies that have benefited from co-funding by CABHI + OBIO, including Genetics Adviser, QurCan Therapeutics, and Lucid.
As momentum builds from the summit, the focus now turns to what comes next: deepening partnerships, supporting innovators, and continuing to strengthen a thriving, self-sustaining Canadian innovation landscape.